Oral 5-Aminosalicyclic Acid Versus 6-Methylprednisolone in Active Crohn's Disease

The response to 5-aminosalicylic acid (5-ASA) in active Crohn's disease was studied in comparison to methylprednisolone in a 24 week randomized double-blind multicentre study. Sixty-two patients were included in the analysis. Thirty were treated with 500 mg 5-ASA qid and 32 with methylprednisol...

Full description

Bibliographic Details
Main Authors: Jürgen Schölmerich, Harro Jenss, Franz Hartmann, Hanne Döpfer, The German 5-ASA Study Group
Format: Article
Language:English
Published: Hindawi Limited 1990-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/1990/260563